Document
Suit aims to block Genzyme acquisition
Boston Globe
-
Boston, Mass.
| Author: | Robert Weisman |
| Date: | Aug 20, 2010 |
| Start Page: | B.7 |
| Section: | Business |
| Text Word Count: | 258 |
A shareholder of Genzyme Corp. has lodged a lawsuit seeking to block Genzyme board members and the French drug maker Sanofi-Aventis SA from completing a deal in which Genzyme would be acquired by Sanofi for a reported offering price of $69 a share, a transaction that would be valued at about $18.4 billion.
Reproduced with permission of the copyright owner. Further reproduction or distribution is prohibited without permission.
Most Viewed Articles (Updated Daily)
• Miss Hilary Olson marries Mr. Meyers
• Touring for peace with Apple Hill players
• TIGER WHIPS LION.
• HUB REACTIONS ARE MIXED TO VERDICT IN GOETZ TRIAL SOME FEAR VIGILANTISM, OTHERS LAUD DECISION
• Rough waters: The public does not have an appetite for political disaster
• Touring for peace with Apple Hill players
• TIGER WHIPS LION.
• HUB REACTIONS ARE MIXED TO VERDICT IN GOETZ TRIAL SOME FEAR VIGILANTISM, OTHERS LAUD DECISION
• Rough waters: The public does not have an appetite for political disaster
Search | Saved Search | Login | Tips | FAQ | Pricing | Account | Help | About | Terms

Abstract
